strandberg
proven
issue
simvastatin
supplied
implementation
taken
nn_1199396
london
colds
experts
medicine
declared
threshold
excluded
contribute
350
going
relieves
wait
autonomously
contributions
rarely
wealthy
offlabel
considers
nzd
fair
ensures
project
advise
estimate
share
2002
oecd
denmark
death
everyone
eur
lies
creates
humanitarian
noting
appropriate
rate
matter
owned
steering
importance
crown
people
treated
conditions
protection
source
beneficiaries
processes
failed
local
outcome
summarising
education
chronically
employ
allowing
therapeutically
whom
viagra
lack
legislates
even
characterised
eligible
ragaz
opas
immediately
dutch
acceptance
consulting
challenges
involve
viewed
los
restriction
serious
minister
better
outpatient
explicit
decentralised
supply
final
cua
liaised
700
lobbying
regulate
already
differently
describing
decentralisation
alberto
subsequent
knowledge
htm
inform
grounds
exchange
incurred
heavily
etc
bougher
tightly
diagnosed
drugs
latter
devices
discontinuation
comparator
position
deal
lowest
varies
personal
allegedly
uncommon
farmacia
subsidy
insurers
continues
ambiguities
financing
table
pbpa
meantime
listings
replacing
boer
impacts
trading
physicians
substantial
web
burden
choosing
partly
references
2007a
set
country
payroll
agent
denounced
met
could
rates
susceptible
ihc
referred
research
considering
survey
bring
hopital
czv
vote
ru486
application
cabinet
laws
provider
procedures
both
quantities
eventually
decisions
lest
vaccine
targeted
sunitinib
prior
mainly
speed
attach
regular
pass
creation
wet
would
administered
stipulated
uncam
adapted
european
significantly
gdp
intravenously
dkma
existence
doing
premiums
global
petrol
recommendation
pancreatic
third
governments
premature
expertengruppen
submission
ovarian
disease
supervising
maladie
dans
underwent
planning
hypertension
bon
interdepartmental
approach
efficacy
essenziali
self
elsewhere
character
prevention
grateful
rather
advisory
district
substitutes
age
expanded
recommended
volume
higher
taxoids
tests
mental
van
results
key
valid
experiences
plan
likelihood
severely
usual
parliament
area
die
pharmacies
preliminary
capable
right
d'etat
necessary
sport
comision
directing
handled
funding
administers
extent
enterprises
card
sick
measures
four
taxes
canton
introduce
opportunities
publicly
hypothetical
sandier
attend
recommendations
affected
kela
600
experience
legislative
individual
who
previously
simple
purchased
desired
haugen
currency
increases
routine
ardy
participation
foremost
exclude
sharing
failure
factors
mandatory
inevitably
institutions
expected
leading
referral
consultations
indication
pre
studies
105
meb
expenses
many
cedac
guaranteed
authorise
operated
activities
considerably
author
she
affairs
utility
act
initiated
enabling
431
provide
cts
utilisation
way
in
receives
universities
124
implications
remaining
german
imported
identified
investment
generics
relates
ontario
patient
illnesses
concerning
possibility
presented
veterans
appraisal
agence
committees
parliaments
shopping
series
vrangbaek
melbourne
variety
account
purchase
resource
pressures
outlines
correctly
combination
tended
carl
relation
uncertainty
lifestyle
beyond
rules
promotes
bodies
hoggard
salaried
increase
von
pharmacy
montilla
providing
canada
2001
aids
published
possible
efficiently
months
earnings
widely
later
kept
prevented
hp
tabled
members
length
law
containing
groot
provincial
folketrygden
past
cost
refund
passed
biological
introduced
neupro
privately
entitlement
1982
excluding
under
contrast
tax
hygiene
molecular
decides
our
its
determined
observations
union
intestines
group
motion
eu
accessed
payment
radio
toxicity
accepted
clarification
medical
soon
paying
remit
tertiary
end
respective
revenues
branded
phiac
funded
submissions
tributaria
supplementary
classified
particular
citalopram
than
without
appeals
just
effective
department
monopoly
surgeon
supervision
reviews
reduction
technology
habl
follow
rapid
woman
2000
approving
resides
pfn
practice
order
following
restrictions
cln_029
data
rationality
labour
opposed
versions
after
inclusive
foley
ups
back
savings
respond
permitted
atorvastatin
opportunity
discharge
grants
repeal
zugelassenen
affirmative
interested
goeteborg
growing
inequalities
difference
1997
perceived
allocated
sorenson
wave
reluctant
eds
compassionate
ordinances
femara
frostelid
kind
plans
statutory
takes
ame
agency
hepatitis
assessment
taxol
2887
organizations
licensed
oncologia
onto
document
php
whole
medications
new
returning
616
centre
evaluation
entirely
composed
reviewed
states
respectively
develop
reimbursed
holders
affordable
prospective
dhb
experienced
cac
negotiation
conclusion
expensive
wide
examples
illegal
regions
your
nikolentzos
variable
consequences
sacred
offers
generalist
2009
swiss
actual
accordingly
occurrence
differ
defines
profile
pbs
resulted
providers
pf
discussions
1990
special
criteria
ultimately
generally
standalone
payable
exceptions
delegating
money
rajaniemi
exceed
actors
probability
eight
reject
obligation
compared
barriers
hryniuk
infusions
combinations
autonomous
relationship
ten
meets
method
her
sought
cipramil
announced
external
any
define
noma
ceps
more
island
tee
patterns
groups
appoints
busse
regarding
ceiling
withholding
report
authorities
class
september
pharmacists
detailed
most
demonstrate
usage
had
information
oncologists
applicants
chronic
gallo
hod
delivered
forming
of
relevant
ct
much
procedure
explained
part
farmacos
doctor
assessing
constitute
seen
stm
drug
refer
upon
only
districts
employer
ill
mossialos
thomsen
basket
prescribed
proposals
aust
means
absolutely
inca
requirements
nacional
livelli
sometimes
remainder
reinhard
193
analyses
reasonable
annum
armed
frankly
voluntary
allopathic
ettelt
interferon
meet
exceptional
into
seven
advanced
weekly
good
making
documentation
dependent
provision
concern
systematic
cumulated
max
abortifacients
state
khoo
probably
wholesale
registered
bell
delayed
nationally
flat
associated
listing
eec
fastest
205
bortezomib
catholic
secured
arts
veto
increasing
come
dignity
preparation
acceso
least
less
helsinki
depending
1993
percentage
400
analysis
decided
introduction
1977
taxation
fixed
received
prescribing
donations
reimburse
almost
froschl
lately
nav
oral
value
expel
duty
antonio
contain
overview
scotia
berlin
laekemedelsfoermansnaemnden
intended
cheaper
merely
ambulatory
company
make
insured
regulatory5
industry
maintaining
august
ministries
advisor
input
suffers
choose
tensions
obligatoire
clauses
utilization
displayed
individuals
schedule
gps
sophisticated
adults
neurology
incentive
secondary
some
applied
copenhagen
arrangement
function
committee
improvement
financial
salud
respect
non
against
joining
practicing
plays
blommenholm
playing
else
society
mesylate
label
lists
benefits
needs
focus
provinces
basis
begin
ability
improve
infectious
profit
dubois
rely
likely
resources
authorises
discuss
newsworthy
deliver
dentists
political
positive
necessarily
illustrated
compensation
analysing
levels
variation
und
rapidly
bevacizumab
com
behalf
remove
assistenza
circumvent
letrozole
france
user
cent
shift
deferred
des
sweden
proximity
pregnant
older
prestations
influential
mondor
product
consider
laender
course
zulassung
treasury
lower
worthwhile
contracted
comprising
specific
follows
precios
agencies
package
becomes
0c0540d1
evenly
switzerland
orally
involved
united
other
newfoundland
metastatic
0001000028ff
worthy
term
oxford
except
university
informs
folfox
principle
visiting
another
parkinson
target
view
fiscal
request
athanasios
inhibitors
2008
unavailable
clinically
2007b
policies
affiliated
neighbouring
antirheumatic
obliged
opinion
exclusively
consultant
movements
3000
ptac
topping
l'activite
finland
pharmacovigilance
walter
gratia
partial
reports
laid
increasingly
office
well
zealand
doctors
recent
news
potential
australia
possibilities
sharp
itemised
governing
sources
folinic
juha
medizinprodukte
achievable
followed
regulated
analogues
towards
lelorier
canberra
linked
acts
decide
resubmit
divided
statins
nazionale
directed
wider
entleiner
meant
abortive
insurance
world
hospital
emergency
greatest
risks
early
databases
trade
breach
amended
deciding
cas
form
journalist
interministerial
supplement
warrants
complementary
confirmation
autonomy
receipt
annual
node
being
december
velferdsvaltningen
stakes
ongoing
costs
derived
statin
automatic
queensland
pubmed
ba
july
possibly
http
earmarked
leads
may
permission
medicinal
sutent
different
physiotherapy
rarity
echocardiograms
terms
attached
immediate
mid
crucial
ace
serves
referentiels
communities
platinium
1992
ordinance
arbeids
thirds
holds
constraints
income
regard
steenhoek
norway
marginal
devolution
plea
manage
hard
number
nevertheless
chf
societies
ownership
organization
comparative
relevance
publikationer
managed
professionals
proposing
universal
population
produce
zealanders
jurisdiction
100
300
prioritising
how
sildenafil
their
best
relating
lottery
therefore
having
morbidities
slowly
financed
dations
included
lara
danish
question
indikationsbereichs
pressure
carried
jurisdictions
required
misconduct
makes
sound
prescriptions
also
related
consultation
cancer
but
too
over
federal
largely
eligibility
criterion
agreement
enclosed
prevent
improving
documented
caring
epidemiological
pay
historical
espanola
believes
degeneration
receive
administrative
evaluations
fund
managing
undertaken
especially
seville
include
unlikely
legally
standing
cut
pensioner
his
evidence
limiting
ordinate
cth
coming
europe
basically
compulsory
dauben
caused
allows
500
based
comparisons
illustrates
rejection
adhere
polton
french
terrain
traditionally
sap
depend
unit
contagious
priority
made
representatives
pockets
nicholas
cvz
johnsen
uses
medicare
teperi
greater
such
borderline
degree
politicians
equivalent
regularly
apply
klazinga
supplier
current
example
exception
sponsor
explicitly
amsterdam
assessed
arzneimitteln
perceptions
alternatives
combining
cantons
member
jon
programme
budgets
unlicensed
eluting
economic
time
maintain
evaluate
dgf
adjuvant
inpatients
strengthen
governed
isabelle
human
evaluating
framework
aroni
expenditure
separately
erlotinib
scientific
invoiced
iterative
renominated
indexed
nine
cell
bibliographic
trivial
cripple
aifa
international
māori
sickness
has
represent
partners
2007
convincing
assessments
unpublished
receptor
ccohta
medica
prioritised
entitled
approve
production
judith
rejections
days
gradual
healthcare
useful
immigrants
redman
updated
macular
antifungals
boxes
medication
contributed
continue
grant
sufficiently
consequence
use
ensuring
territories
despite
niezen
reimbursable
until
10a
citizen
practitioners
maker
confronted
ageing
weighted
mifepristine
pricing
box
therapy
t2a
appeal
trastuzumab
forces
views
travelled
cancers
conference
mentioned
aide
charge
events
bill
durand
broadening
rare
og
facility
erbitux
essential
march
pharmacoeconomy
typical
priorities
safe
indenrigs
appropriately
accountable
subsequently
karlberg
growth
unfunded
hoc
established
lamal
via
spent
responsibility
delisting
regulatory
surveillance
negotiations
agencia
issued
involves
efficiency
range
2008b
solidarity
medium
rebates
particularly
effect
beta
stay
declined
administering
advises
search
perspective
inhibits
jul
trying
gives
major
issues
place
primary
acknowledgements
above
substitutive
partici
competition
play
lausanne
manufacturers
recommend
email
aid
modest
million
constraint
chamba
serve
obsolete
debated
concessional
psychiatry
matters
charges
transparently
previous
recurrent
consistently
regional
prince
reduce
bernt
access
board
land
101
elaborate
accessibility
breast
senator
retail
placed
presence
setting
osteoporosis
drummond
goal
inequitable
type
authority
defer
vogler
sehdev
situation
endorsed
supported
nature
note
there
amend
regardless
patent
market
180
pharma
anwendung
south
gibson
formerly
partially
provides
soins
top
duplication
acquisition
certain
professional
meeting
varying
sozialgesetzbuch
directly
precedence
amount
recommen
occurs
few
government
authors
told
rejected
diagnostics
occasionally
price
engines
nis
rebate
should
promised
selected
cfh
seek
necessity
predominantly
applying
forcing
nza
products
interest
nonmarketed
frequently
poor
pharmaceuticals
undesirable
undertaking
therapies
waiting
clinical
treatments
rejects
build
index
antagonists
proposed
off
rome
cardholders
treating
known
entecavir
differences
affordability
additional
director
norm
person
aimed
kanavos
supplemental
harvey
positively
objectives
inpatient
line
dollar
deliberations
result
constitutional
paclitaxel
registration
solution
reflecting
findings
house
gov
plus
automatically
ministerial
innovations
centres
houses
need
does
outside
per
performed
validated
fewer
process
whereas
sns
principally
extras
trials
1990s
working
packages
switzerland4
consulted
indicated
statistics
rasmussen
print
program
reform
rotigotine
power
code
substance
acronym
although
period
claim
statute
important
annals
bundesinstitut
comparison
all
bruet
british
informants
2006
units
systems
practically
mays
total
development
support
1984
add
submit
surgery
factor
physician
control
including
allan
provisions
unless
sciences
created
surgical
itself
mostly
applications
agree
premium
negative
religious
institutional
transport
fee
budget
assisting
html
create
below
during
velcade
encountered
multiple
ministry
greatly
s100
hta
cases
agrees
temporary
accessing
chosen
equally
methods
contracts
adviser
recently
duration
radiology
mandated
writing
decreasing
call
h2
distributed
items
judging
relative
contract
courts
nsclc
open
significant
importantly
magnitude
surveying
participating
forms
neutral
inclusion
consumers
pharmacotherapy
predict
lfn
intravenous
shared
simultaneous
amd
legislation
nolte
vignette
disabilities
pack
they
adopt
spanish
journals
fairly
adverse
diagnosis
experimented
benchmark
aiming
sales
rational
swedish
fuer
regulators
medsafe
amongst
clinic
annex
region
according
bundesanzeiger
contributing
prolonging
administrators
monthly
options
joint
showing
290
mandate
staff
release
cdr
defining
manufacturer
overt
media
radiation
submitted
supervised
questionnaire
main
supports
classification
coordinating
basic
iqwig
alternative
broadly
advice
nzphd
effects
receiving
lung
newly
cards
avastin
dilution
concerned
buy
implication
reasonably
conventional
life
extend
subject
herceptin
marketing
odd
symptoms
roche
system
month
uncertain
every
enrolled
overseen
appears
national
larsen
controversial
pharmac
policy
addition
charitable
risk
formally
assurance
brand
care
addressed
weigl
beginning
budgetary
highly
italian
infirmieres
on
restructuring
benefit
study
accessible
yahoo
arm
fundamental
chemotherapy
specialites
outcomes
family
errors
visit
implemented
case
surgeons
reportedly
untreated
intends
effectively
prescribe
injuries
pharmaceutical
down
about
html__nnn
defined
inclusions
blockers
calcium
prove
inappropriate
exceeds
girls
addresses
administer
unusual
technical
200
cetuximab
extra
own
goods
regulating
monitoring
regulator
duran
improved
obtaining
security
curative
productos
costly
advised
arzneimittel
transfers
operation
bisphosphonates
departments
marketed
includes
citizens
competing
active
happened
accounting
impact
formulation
achieved
run
manufacturing
raising
severity
precedent
lin
hansen
please
justification
lucentis
deductibles
drs
quebec
contents
subordinate
pbac
869
suppliers
currently
independently
signs
added
ineffective
channel
remains
home
organising
provided
couple
prescription
judged
societal
variations
removed
relatively
confederation
counties
annually
assesses
fluvastatin
er
chemical
bulk
treatment
turpie
types
commissioned
monitor
abroad
henri
subsidies
long
complemented
applies
orphan
determine
specialists
deductible
become
2750
commissions
category
expect
central
history
fit
entering
consideration
dental
peoples
jackson
several
cipe
arrangements
commission
assistance
levy
chose
lead
remeikis
comparable
shi
wishes
might
schemes
tend
mechanism
entitlements
welfare
treat
whose
corresponding
council
compiling
heart
answering
rheumatology
challenging
guarantee
2005
kurkijarvi
beings
aims
trusts
encourage
second
glyvec
scheme
disability
advocacy
1953
wishing
october
observatory
sistema
reported
furthermore
fall
work
generous
psychiatric
technologies
niek
sell
conducted
directorate
service
whether
guidance
three
dacehta
reference
specifically
mix
settings
differs
was
governance
purchases
two
jointly
each
deny
paciente
wish
ranibizumab
role
court
assess
technique
2008a
government_reform_in_brief
l'hospitalisation
consult
attention
minor
tecnicas
mixed
tamoxifen
oncologist
economics
tropical
indications
weight
countries
suggests
full
fees
whereby
strengthened
direccion
half
gowing
fifth
biologic
limit
available
montreal
stargardt
approved
protocols
servants
however
qualify
communicated
municipal
italy
patients
consequently
sum
confidential
subsidises
one
barreras
edward
brief
formularies
employee
franchise
estimated
prepare
decision
allowed
outlined
institution
year
net
sociedad
lawsuits
preventive
paris
assignment
sur
among
considered
threatening
nominated
undertake
l'information
transparent
approval
operates
evaluates
directive
mpa
bowel
conscious
subset
ley
proportion
january
3__nachder
competitive
reasons
private
waveren
listed
palliative
rule
objective
still
direction
cover
maternal
will
medicines
covering
average
practices
network
exempted
future
cause
quite
carcinoma
very
emphasis
associations
usually
status
requiring
colorectal
advances
expertise
charging
became
payments
numbers
exactly
thereby
prognostic
480
oversight
indeed
preferably
dedicated
demand
journal
ratio
payer
then
markers
coverage
netherlands
bear
governmental
vitamins
de
resident
direct
underlines
australiandoctor
moderated
quantity
billion
columbia
involving
facilities
weeks
civil
enabled
due
oncologicos
pending
guided
stipulates
frequent
rays
discretionary
sponsors
six
haematologist
independent
quality
outpatients
often
reflect
ottawa
decline
tarceva
thus
daily
restricted
similar
municipalities
evaluated
changes
emea
nations
areas
described
indicate
same
alberta
seeks
dispensed
accidents
free
operate
license
sons
vignettes
allow
yields
larger
others
tool
campaign
sclerosis
inflammatory
nova
renal
transition
mount
sector
asthma
seom
here
constitutes
organisationally
gdp3
entity
aspects
nzphda
raised
spread
clarify
expressed
sanitarios
given
ensure
yet
aged
pfizer
laxatives
denied
determines
separate
official
vallgårda
principal
pensions
offset
between
sveen
dispense
restrictive
rigorous
authorising
book
parts
medicamentos
agreements
determining
territory
put
subsidised
cadth
province
decrees
acceptable
savage
willing
expert
conversions
acute
motive
les
trial
contexts
offer
peura
profiles
transferred
financially
organisations
formulary
publication
women
www
coalition
adequate
therapeutics
controlled
public
ingredient
approx
fully
diseases
essentially
brunswick
entry
programmes
taking
produces
children
theoretically
day
problems
mckee
agents
115
cantonal
socioeconomic
must
england
cavity
body
characteristics
sections
illness
drugs8
able
gbp
companies
using
justify
single
vienna
pocket
since
advantage
reactions
critical
oxaliplatin
residents
1996
unlimited
qualifications
diabetes
nhs
ever
modalities
sale
normally
clinicians
admitted
consumer
sets
upper
clinics
google
literature
clearly
sanitario
lost
always
tone
boards
constitution
county
written
founding
limited
unable
thomson
acc
prohibited
completed
pays
directors
austrian
within
obtained
lu
led
0510002
erectile
grosvold
imatinib
tariff
organised
covers
obtain
verification
elect
spare
2004
canadians
leopold
generate
reimbursement
priced
response
tga
because
condition
depends
rights
specialty
knai
skills
norwegian
minimisation
travel
spain
legal
level
covered
youth
gemeinsamer
supplemented
baraclude
asked
illustrate
saskatchewan
occurring
sundhedsministeriet
judicial
centrally
pravastating
spleen
done
subsidising
historically
pacific
idea
management
stents
guidelines
confirm
iems
experimental
equal
liste
cluster
docteur
corporatist
terminally
mother
broad
delivery
vary
longer
atih
ceuticals
indicates
originally
them
macneill
tc
relativity
oncological
used
expanding
tends
true
certify
users
nor
considerable
press
when
ndfp
responsible
background
employs
reached
terri
pharmacoeconomic
acknowledge
proposal
liability
finance
assigns
quickly
otherwise
nurses
advent
exclusion
accept
grouped
martini
healy
camptosar
tuscany
yes
debate
secure
shall
further
perspectives
sign
change
dispensing
ought
developing
summary
influence
called
responsibilities
rests
institute
prolong
sold
questionable
toronto
ministers
exclusions
regulation
territorial
centralised
specialised
800
comprehensive
herbs
considerations
inefficient
pertaining
dhbs
administration
suitability
negotiated
tradition
swissmedic
promising
names
adjusted
specialisation
capacity
point
confirming
dysfunction
oncology
williams
insurer
gist
000
authorisation
functions
specified
cox
small
therapeutic
nok
found
limits
association
275
enables
instead
rastuzumab
canadian
former
antony
expectations
ask
sante
overturned
low
aud
devolved
extension
across
through
while
thedaily
theoretical
reviewing
levied
funds
held
australian
take
purchasers
regulations
developed
seeking
purposes
occasions
claimed
sii
colucci
transfer
formal
licensing
school
negotiates
hospitals
try
drg
circumstances
amendment
bundesausschuss
judgement
fell
capabilities
once
purpose
expired
irinotecan
hospitalisation
gregersen
councils
present
minimal
pharmacist
intervention
see
iv
pensioners
recommends
tarification
bfarm
italy1
draw
either
common
ofsp
health
krasnik
pating
innovative
throughout
refundable
paragraph
commonwealth
review
zaleski
applicability
supposed
lshtm
gradually
regnet
rehabilitation
interpreted
general
finnish
maximum
restrict
mechanisms
authorised
beveridge
five
victoria
stipulate
ultimate
concerns
ganse
fertility
prepared
funder
adult
list
out
projected
accident
germany
lnf
seem
leave
falls
sectors
stage
core
servizio
simplest
specialist
section
size
appointed
srivastava
2892
zvw
categories
publish
side
ppb
productivity
fluorouracil
tasks
organisation
social
affair
generic
cooperating
acid
safety
requires
looking
controversy
minus
vaccination
paid
anecdotal
nhi
gazette
ellen
majority
moderately
carry
subsidise
name
spirit
simply
commit
learn
prices
hpv
nursing
involvement
extending
certainty
transparency
stolk
existing
refers
reimburses
schedules
protocol
require
ethical
requirement
pharmacology
contribution
manitoba
asp
claims
payers
nielsen
holly
consists
works
noted
medicale
sl
interventions
highest
unsuitable
granted
around
ricciardi
cannot
binding
along
not
mark
years
loss
practitioner
incremental
prioritisation
spectrum
principles
effectiveness
remain
division
equity
specifies
hiv
informed
uptake
severe
ordonnance
services
reduced
ausserhalb
party
counter
times
stakeholders
standard
faculte
community
universally
before
ingvar
notified
represents
persons
minerals
jr
team
disabled
prescribes
room
high
availability
parliamentary
postcode
first
arild
requests
laekemedelsverket
overall
lovastatin
sub
structure
2003